Motivation to quit smoking among hospitalised individuals with and without mental health disorders.
BACKGROUND
Persons with mental health disorders (MHD) have higher rates of smoking and poorer cessation of smoking outcomes than those without MHD. A decreased level of motivation may partially explain lower cessation rates, but there is little information on motivation among inpatients with MHD.


OBJECTIVE
Primary aims were to compare (1) motivation to cease smoking among those hospitalised with MHD or non-MHD, (2) the proportion that attempted smoking cessation, and (3) use of aids to cessation. A secondary aim was to assess cessation up to six months post-discharge.


METHODS
Smokers were recruited at a tertiary hospital in Perth, Western Australia. Surveys were administered upon admission and at 5 and 14 days and 6 months post-discharge.


RESULTS
We recruited 64 MHD inpatients and 43 non-MHD inpatients. At baseline there were no significant differences between the groups on any measures of the five measures of motivation. Significantly more of the MHD sample attempted smoking cessation than those in the non-MHD sample (34 versus 13: chi(2)(1)=5.472, P=0.028). Nicotine replacement therapy (NRT) alone was used by 70% of those attempting to quit but was only provided as part of discharge medication to two people and few persons (<21%) in either group used NRT post-discharge. By 14 days, three (4.7%) of the MHD group and none (0%) of the non-MHD group reported abstinence, at 6-months one from each group reported continuous abstinence since discharge from hospital.


CONCLUSIONS
Motivation to cease smoking among inpatients with MHD was similar to those without MHD, as was use of NRT while hospitalised. The low provision of post-discharge NRT may contribute to the poor cessation of smoking outcomes and does not fulfil evidence based guidelines.
Siru
Ranita
R
University of Western Australia, Queen Elizabeth II Medical Centre, Nedlands, Australia.
Hulse
Gary K
GK
Khan
Riaz J K
RJ
Tait
Robert J
RJ
D000279:Administration, Cutaneous; D000328:Adult; D016009:Chi-Square Distribution; D005260:Female; D006801:Humans; D007297:Inpatients / Q000523:psychology*; D008297:Male; D001523:Mental Disorders / Q000523:psychology*; D008875:Middle Aged; D009042:Motivation; D009538:Nicotine / Q000627:therapeutic use; D012907:Smoking / Q000188:drug therapy / Q000523:psychology; D016540:Smoking Cessation / Q000523:psychology*; D011795:Surveys and Questionnaires; D016896:Treatment Outcome; D014904:Western Australia
D009538:Nicotine